{"ticker": {"uuid": "dd76698a-43a1-45d7-8c13-61c7cab307a9", "symbol": "6855", "name": "Ascentage Pharma Group International", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Ascentage Pharma Corrects AGM Date for Share Incentive Scheme Mandate", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNUDN2Y2d0VkVTRXJUQ21IZ2NEV1I1cGxZSHVTR3FPOHNTMmIzNkNEaGRUbzhPWFRyZmhXVUttbzRrSHdCeTB5RUItWVRvcDk5b1doQVBKU0VJTmREcXYzU3AzZ2R2ZFZqbE82QTZwOElucmFjUHBMRzdLS3B2anhvSEZXWEVZNVI0dG5EdnZ1YmlGbVd0T2tsQkJwNmJ6YXIxc09vNzB5dVlDek1zLVRSRE9zOFpSVnY5eGRJX0Jn?oc=5", "source_name": "TipRanks", "published_at": "2026-07-13T00:15:23+00:00", "published_display": "13 Jul 2026 00:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma (SEHK:6855) Stock After New ASCO 2026 Data A Fresh Look At Valuation", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Ascentage Pharma Group International\u2019s Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPYjk2WWd1YXZWeXYyZFNjTVc0Y3htdnJsRVJGTWRzbzZYQVk0dUlMOWF2WHJEN0tlLTd4d25UWHBEVGhEQXV5c3NIVlIzWER5SHk0ZkJxWFBBVnd4c3VKWER3ajRfN3RvNjdZanMwRk14b1VjTHhTMWlrN1djWHZ1ZGRySGhGM3psU2ZRMXdWUURiV0poMUE3dV9LY1Z2ekRlTEJiY1d4MC1MZw?oc=5", "source_name": "Market source", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Have Lowered Expectations For Ascentage Pharma Group International (HKG:6855) After Its Latest Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE1HbTRHUjdMY0wxbHlBZ2VaM2V0aGZoTDRBZDJDcTEzVnJtNUVXTTdCdTdFWGwtWDZkOFUzMXJDeHlIY1NXTVo0SlhwcEZjbVVfdFZKSm12ZGg?oc=5", "source_name": "webull.com", "published_at": "2026-03-28T07:00:00+00:00", "published_display": "28 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAJBVV95cUxQZjJFWnc5cjFaTkR0R0xaeTFVVWRGS1BfNHdzbmh0SUFYdTJNSEJDR0pneGNfUTViTlpvSVVrTVlpXzU2ZEVFdGJFME5Gdll5VGFGdzBiMWxCUDZlYVVZdGtvQk55RWhBOFdfc09sZ2kxNnU5X244RGNFYnJNRDF5dEo1UE1hci1CVzZyeDZneWlLWTNXUHJjVXZnc1phWmRJRkVjNEJUTnFzRVNnYU5VZWxEMm9IVmhFWTJyeTF6TV9mSlh6ZUVvWlV5Q3NOc2pWaVFwTl9iYmJldUZocUJJTTJqUEo2TnN6cHRjT3hPWXJuZl9FLU5MbXJfRTFpSzNoQkVHdW9Oa3NwT0Q3RTJGc0V5T0xycThSMkZRUUU4eTh3T3RyQ1Y0bm01TFBGc3dXV0FxNlAzVmtoRjFvaEFjdm9Zblc?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-07-07T07:00:00+00:00", "published_display": "07 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Appoints Dr. Veet Misra as CFO and Eric Huang as SVP of Global Corporate Development and Finance", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxPZVRGeG04WUVfbHRPSkdROVVKczU0VmVpS3pWTlJOS203c2lXS2N2YUZKdU1TMnRmMWdndGJXVGtiSk9LbGkwSFpjanZId1M1OU1LWF9SRE5GUXZfZS1LaXQ3Zm1DemgwcUNOdW0xblY0bzVXeWRwVTdKYllBaEg4N25qS0p0Y2hWQkJGdm5OUkRfcGZlcWRtR3RBMkNUOG5GWVlkekxobTlhWVNrSnFEQ1lxTzlmLTlsZGNmLUVFYU11a3FVN3dHdzNBQVZHbnlSWWdsUUtHZnZLa0tuVDJqZU4tMHJvdw?oc=5", "source_name": "citybiz", "published_at": "2025-07-07T07:00:00+00:00", "published_display": "07 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Group International (AAPG) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBYSnZYMURPZEpZNW90bEZrSkNzNWp4aHVRT1hMRkxUN25wRi1nZFlNYWpCSEpiS0JNNFh2YmctQnlCT3VlN0hNQnpUdDM2U3BaMzRB?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T15:42:33+00:00", "published_display": "25 Apr 2025 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma to Report Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAJBVV95cUxNME03dTlqOHlYUnZtVmFzclNGYjZyVkFqR1ZWb1ZtbHdEQWFoN0ZpeURnVkdNNjMzUWp4S3dfb2xLdjJ6bExGa2YxN2tiTDdGSW1ObXhXTUdRMUMtbkh2eXB3UHE3dFpkY3RwTjAtQW93R2lXZWlpU3JCeTlJTXBDdWU4TjMtNEZXZzYzeXVCdkZQQ3BidHRPVXYxaFBOQnlZZTNLY1ZONzV6YzJjVmd0di13TVJOSExVMzhHRnYtelpUX21kVkNCVWtteU50SC1lektWa1QwekhLOXhGYVI0WG12R2lYQWNsdWFDUjNfUHdhWXo1UWpoVlktOFF4OHc0X1FLZUZLbDI0aC1J?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-03-12T07:00:00+00:00", "published_display": "12 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wilson Sonsini Advises Ascentage Pharma on U.S. Initial Public Offering and Nasdaq Listing", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOWThTdDd1amtNemd6TlRCNGo1cHV0ZGphUmViV1NBYkFZaFVaN3VteFFPY1pOWHlRamJEczZEZG5heE4wblRpY2tGNlhmVUN5MWxnSEhfNks1UVMza2RsLWQyQ2tnVllnU2NUQXkzS3RCc1U1cnFDTHVqS01MRDA4Y0plQWhYb3NyWEVrRXhRTHBSR0RwTkdoZUdwNC1VR0JBUjlUbWFNUXlPN3RFT3o2MV9HNVNHdWIyM0dwQ0VLaFFTMTFm?oc=5", "source_name": "Wilson Sonsini", "published_at": "2025-01-28T08:00:00+00:00", "published_display": "28 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the World", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQSE83VTRDTDVpUHlsNzRoMHFNMlFCTDZmM1pVWmdnWTZvNW13WGJzZm9KUlNTQjBqcWNJbXh5VzkzWVlZNzA4TExzei1ucmlLaU1iRFJaRGJNNVV0VzYxMTBkRzFrWVdjRF9JLUNrODBOd01sTWN6dFphbkRYZndvV1RpRzlMblhEcXc?oc=5", "source_name": "MedCity News", "published_at": "2025-01-24T08:00:00+00:00", "published_display": "24 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rockville's Ascentage Pharma seeks to raise $134M in U.S. IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOWnRFRmtGTmRUT2Jta1QwR1B2NHZFN0xLcmY2ZzZQYlRlY2VIUVJGaDNRSFAyckt3VE8wRVZ4WWMyT0Q5X003ZlVjb2U5cFJRRElTaWlHWFNxNXhuRk1ZYlFUR2hENGJzOEV6UFo0NEthRjNwR0x5RlpNRWxJUlBRV1dCYm4ybGtDM2t4Y0UzbVJNUlhLYWtOeTk1S2pIT2tHMjlPa3ZQUmg?oc=5", "source_name": "The Business Journals", "published_at": "2025-01-23T08:00:00+00:00", "published_display": "23 Jan 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage prices first biotech IPO of 2025, raising $126M", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPMUNPSEJxZVpOa3RUMm80SGJBSXozeGxrd2UtU19JZUMyRnV0bzRJRGNkVHJraG5rbC1fR1gyT2tCREtvcGdhYmtYTVlfMy1JMlZ3X0ZmZG9ZWlgycWZGaVpqTW1NbHE0VTlXMklUN1JTVkxjbXhVVi1KRlJHM3RmMjMycVFuZ0ZLZGhn?oc=5", "source_name": "BioPharma Dive", "published_at": "2025-01-23T08:00:00+00:00", "published_display": "23 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma sets terms for $149 million US IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNbUNyRVMwRlVhQVlmWEplY25IUUVaM0cyUHdWZ05oNVJRcXFCLVFLODBqU2NaY1EyOEJXUXV6aDl5QV8xWFZVbTF3cHcxRGs3M0JnM3E1VTg0ampMWGNuQmNhaURINVh5am5iYklTdU01YVRMMnVjYm1waTFSa0xGQ1BUamdLUU94c1hjYjhVdmZsTHM?oc=5", "source_name": "The Pharma Letter", "published_at": "2025-01-22T08:00:00+00:00", "published_display": "22 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BMS, Takeda's Chinese partners file for IPOs, sending Ascentage, Biokin and Bao bundling toward listings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOckxFUHctbHVFTG1xRTVTUlhKR2Z0dkdLN3k5OWxYdy0yZFdIb0VkWnQydEJTUG9HRGxHZzJCZkVDNFNYWlJpZWNDdEpNS1lqck4zOWJlN3hjMkRwSGNlQ3Q3alItdjVHOWxiaUUyQjVDdHMyb0pSeTZuSFVMU0xFVHM5Y3RPcUlkem1SWWpYMjNiMkpQWXRPQjdnOHZId3RMZGNvZXVNVk8wVGcySlFzZVBzMHo3NWV1NUlzR2Q4RWNxd0U?oc=5", "source_name": "Fierce Biotech", "published_at": "2025-01-22T08:00:00+00:00", "published_display": "22 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Received US$100 Million Option Payment from Takeda", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNSk1rM2h5eEZ2bUhlaUViZ2l2eTRkT0dvVVZLTG53eUtsVThNdU4zUmFadFMybUo3UE5CV1Z2VnZWODMzemhPUjc4ZEZpVHRwYi1GR1ExaWVhUEVnRk9RSHRha1VFbTRYZktqTnkwVlQtS3NycUlaMW9VQTNQQjNoSmJBSWpQNzlhY1BCT3dyRzR0N3UxQXFJUw?oc=5", "source_name": "Macau Business", "published_at": "2024-07-04T07:00:00+00:00", "published_display": "04 Jul 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQaFZ5b0V4Z0tpX1ZOdXpHZTFPbk96QzJLYVFJang3QW45aEw2bVFhYk56VW9YMjJUM21kc3puNjdNdTdwRjZsR0J6UWRpNDVWWVlfVlRiWXQxZW1NTDRZbndweVpOLTkwWTV6NWg4VGpVclBkeDJxMEdMaXFFbmd2MzN1Q0hiUkIzX1A3azhMRk9HSWQ5Q290MjNiNTNqOVJnTlZPN25sZnUtdDRiY0ljZXRKWktISDhCMEVUOHBsTnpnbE9rWjUwZmlXT1RXMXc?oc=5", "source_name": "PR Newswire", "published_at": "2024-06-20T07:00:00+00:00", "published_display": "20 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma signs R&D, commercialization deal worth up to $245M", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOR3JXeWFTSUxEaG9FdzdrSWJDRzdEMzRLMms5N3VnVEJGamthR3BqeTRLQW5wX214NnZDLS1lekxQY2k1Z1BmVVNYSGFaLWlZNWM1Rk0tNVU3dFhycEkzNDJRR3h0VmszRjhMcFh0eElCcXdrbkgzYzJOX1BYOVFXY1ZJS3pqX2w5aElaY3gtN0FSbVdBNEpwN3RoV1pnUUFoUlh4OA?oc=5", "source_name": "The Business Journals", "published_at": "2021-07-15T07:00:00+00:00", "published_display": "15 Jul 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Ascentage Pharma Corrects AGM Date for Share Incentive Scheme Mandate", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNUDN2Y2d0VkVTRXJUQ21IZ2NEV1I1cGxZSHVTR3FPOHNTMmIzNkNEaGRUbzhPWFRyZmhXVUttbzRrSHdCeTB5RUItWVRvcDk5b1doQVBKU0VJTmREcXYzU3AzZ2R2ZFZqbE82QTZwOElucmFjUHBMRzdLS3B2anhvSEZXWEVZNVI0dG5EdnZ1YmlGbVd0T2tsQkJwNmJ6YXIxc09vNzB5dVlDek1zLVRSRE9zOFpSVnY5eGRJX0Jn?oc=5", "source_name": "TipRanks", "published_at": "2026-07-13T00:15:23+00:00", "published_display": "13 Jul 2026 00:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma (SEHK:6855) Stock After New ASCO 2026 Data A Fresh Look At Valuation", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Ascentage Pharma Group International\u2019s Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPYjk2WWd1YXZWeXYyZFNjTVc0Y3htdnJsRVJGTWRzbzZYQVk0dUlMOWF2WHJEN0tlLTd4d25UWHBEVGhEQXV5c3NIVlIzWER5SHk0ZkJxWFBBVnd4c3VKWER3ajRfN3RvNjdZanMwRk14b1VjTHhTMWlrN1djWHZ1ZGRySGhGM3psU2ZRMXdWUURiV0poMUE3dV9LY1Z2ekRlTEJiY1d4MC1MZw?oc=5", "source_name": "Market source", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Have Lowered Expectations For Ascentage Pharma Group International (HKG:6855) After Its Latest Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE1HbTRHUjdMY0wxbHlBZ2VaM2V0aGZoTDRBZDJDcTEzVnJtNUVXTTdCdTdFWGwtWDZkOFUzMXJDeHlIY1NXTVo0SlhwcEZjbVVfdFZKSm12ZGg?oc=5", "source_name": "webull.com", "published_at": "2026-03-28T07:00:00+00:00", "published_display": "28 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAJBVV95cUxQZjJFWnc5cjFaTkR0R0xaeTFVVWRGS1BfNHdzbmh0SUFYdTJNSEJDR0pneGNfUTViTlpvSVVrTVlpXzU2ZEVFdGJFME5Gdll5VGFGdzBiMWxCUDZlYVVZdGtvQk55RWhBOFdfc09sZ2kxNnU5X244RGNFYnJNRDF5dEo1UE1hci1CVzZyeDZneWlLWTNXUHJjVXZnc1phWmRJRkVjNEJUTnFzRVNnYU5VZWxEMm9IVmhFWTJyeTF6TV9mSlh6ZUVvWlV5Q3NOc2pWaVFwTl9iYmJldUZocUJJTTJqUEo2TnN6cHRjT3hPWXJuZl9FLU5MbXJfRTFpSzNoQkVHdW9Oa3NwT0Q3RTJGc0V5T0xycThSMkZRUUU4eTh3T3RyQ1Y0bm01TFBGc3dXV0FxNlAzVmtoRjFvaEFjdm9Zblc?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-07-07T07:00:00+00:00", "published_display": "07 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Appoints Dr. Veet Misra as CFO and Eric Huang as SVP of Global Corporate Development and Finance", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxPZVRGeG04WUVfbHRPSkdROVVKczU0VmVpS3pWTlJOS203c2lXS2N2YUZKdU1TMnRmMWdndGJXVGtiSk9LbGkwSFpjanZId1M1OU1LWF9SRE5GUXZfZS1LaXQ3Zm1DemgwcUNOdW0xblY0bzVXeWRwVTdKYllBaEg4N25qS0p0Y2hWQkJGdm5OUkRfcGZlcWRtR3RBMkNUOG5GWVlkekxobTlhWVNrSnFEQ1lxTzlmLTlsZGNmLUVFYU11a3FVN3dHdzNBQVZHbnlSWWdsUUtHZnZLa0tuVDJqZU4tMHJvdw?oc=5", "source_name": "citybiz", "published_at": "2025-07-07T07:00:00+00:00", "published_display": "07 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Group International (AAPG) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBYSnZYMURPZEpZNW90bEZrSkNzNWp4aHVRT1hMRkxUN25wRi1nZFlNYWpCSEpiS0JNNFh2YmctQnlCT3VlN0hNQnpUdDM2U3BaMzRB?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T15:42:33+00:00", "published_display": "25 Apr 2025 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma to Report Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAJBVV95cUxNME03dTlqOHlYUnZtVmFzclNGYjZyVkFqR1ZWb1ZtbHdEQWFoN0ZpeURnVkdNNjMzUWp4S3dfb2xLdjJ6bExGa2YxN2tiTDdGSW1ObXhXTUdRMUMtbkh2eXB3UHE3dFpkY3RwTjAtQW93R2lXZWlpU3JCeTlJTXBDdWU4TjMtNEZXZzYzeXVCdkZQQ3BidHRPVXYxaFBOQnlZZTNLY1ZONzV6YzJjVmd0di13TVJOSExVMzhHRnYtelpUX21kVkNCVWtteU50SC1lektWa1QwekhLOXhGYVI0WG12R2lYQWNsdWFDUjNfUHdhWXo1UWpoVlktOFF4OHc0X1FLZUZLbDI0aC1J?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-03-12T07:00:00+00:00", "published_display": "12 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wilson Sonsini Advises Ascentage Pharma on U.S. Initial Public Offering and Nasdaq Listing", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOWThTdDd1amtNemd6TlRCNGo1cHV0ZGphUmViV1NBYkFZaFVaN3VteFFPY1pOWHlRamJEczZEZG5heE4wblRpY2tGNlhmVUN5MWxnSEhfNks1UVMza2RsLWQyQ2tnVllnU2NUQXkzS3RCc1U1cnFDTHVqS01MRDA4Y0plQWhYb3NyWEVrRXhRTHBSR0RwTkdoZUdwNC1VR0JBUjlUbWFNUXlPN3RFT3o2MV9HNVNHdWIyM0dwQ0VLaFFTMTFm?oc=5", "source_name": "Wilson Sonsini", "published_at": "2025-01-28T08:00:00+00:00", "published_display": "28 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the World", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQSE83VTRDTDVpUHlsNzRoMHFNMlFCTDZmM1pVWmdnWTZvNW13WGJzZm9KUlNTQjBqcWNJbXh5VzkzWVlZNzA4TExzei1ucmlLaU1iRFJaRGJNNVV0VzYxMTBkRzFrWVdjRF9JLUNrODBOd01sTWN6dFphbkRYZndvV1RpRzlMblhEcXc?oc=5", "source_name": "MedCity News", "published_at": "2025-01-24T08:00:00+00:00", "published_display": "24 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rockville's Ascentage Pharma seeks to raise $134M in U.S. IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOWnRFRmtGTmRUT2Jta1QwR1B2NHZFN0xLcmY2ZzZQYlRlY2VIUVJGaDNRSFAyckt3VE8wRVZ4WWMyT0Q5X003ZlVjb2U5cFJRRElTaWlHWFNxNXhuRk1ZYlFUR2hENGJzOEV6UFo0NEthRjNwR0x5RlpNRWxJUlBRV1dCYm4ybGtDM2t4Y0UzbVJNUlhLYWtOeTk1S2pIT2tHMjlPa3ZQUmg?oc=5", "source_name": "The Business Journals", "published_at": "2025-01-23T08:00:00+00:00", "published_display": "23 Jan 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage prices first biotech IPO of 2025, raising $126M", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPMUNPSEJxZVpOa3RUMm80SGJBSXozeGxrd2UtU19JZUMyRnV0bzRJRGNkVHJraG5rbC1fR1gyT2tCREtvcGdhYmtYTVlfMy1JMlZ3X0ZmZG9ZWlgycWZGaVpqTW1NbHE0VTlXMklUN1JTVkxjbXhVVi1KRlJHM3RmMjMycVFuZ0ZLZGhn?oc=5", "source_name": "BioPharma Dive", "published_at": "2025-01-23T08:00:00+00:00", "published_display": "23 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma sets terms for $149 million US IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNbUNyRVMwRlVhQVlmWEplY25IUUVaM0cyUHdWZ05oNVJRcXFCLVFLODBqU2NaY1EyOEJXUXV6aDl5QV8xWFZVbTF3cHcxRGs3M0JnM3E1VTg0ampMWGNuQmNhaURINVh5am5iYklTdU01YVRMMnVjYm1waTFSa0xGQ1BUamdLUU94c1hjYjhVdmZsTHM?oc=5", "source_name": "The Pharma Letter", "published_at": "2025-01-22T08:00:00+00:00", "published_display": "22 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BMS, Takeda's Chinese partners file for IPOs, sending Ascentage, Biokin and Bao bundling toward listings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOckxFUHctbHVFTG1xRTVTUlhKR2Z0dkdLN3k5OWxYdy0yZFdIb0VkWnQydEJTUG9HRGxHZzJCZkVDNFNYWlJpZWNDdEpNS1lqck4zOWJlN3hjMkRwSGNlQ3Q3alItdjVHOWxiaUUyQjVDdHMyb0pSeTZuSFVMU0xFVHM5Y3RPcUlkem1SWWpYMjNiMkpQWXRPQjdnOHZId3RMZGNvZXVNVk8wVGcySlFzZVBzMHo3NWV1NUlzR2Q4RWNxd0U?oc=5", "source_name": "Fierce Biotech", "published_at": "2025-01-22T08:00:00+00:00", "published_display": "22 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Received US$100 Million Option Payment from Takeda", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNSk1rM2h5eEZ2bUhlaUViZ2l2eTRkT0dvVVZLTG53eUtsVThNdU4zUmFadFMybUo3UE5CV1Z2VnZWODMzemhPUjc4ZEZpVHRwYi1GR1ExaWVhUEVnRk9RSHRha1VFbTRYZktqTnkwVlQtS3NycUlaMW9VQTNQQjNoSmJBSWpQNzlhY1BCT3dyRzR0N3UxQXFJUw?oc=5", "source_name": "Macau Business", "published_at": "2024-07-04T07:00:00+00:00", "published_display": "04 Jul 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQaFZ5b0V4Z0tpX1ZOdXpHZTFPbk96QzJLYVFJang3QW45aEw2bVFhYk56VW9YMjJUM21kc3puNjdNdTdwRjZsR0J6UWRpNDVWWVlfVlRiWXQxZW1NTDRZbndweVpOLTkwWTV6NWg4VGpVclBkeDJxMEdMaXFFbmd2MzN1Q0hiUkIzX1A3azhMRk9HSWQ5Q290MjNiNTNqOVJnTlZPN25sZnUtdDRiY0ljZXRKWktISDhCMEVUOHBsTnpnbE9rWjUwZmlXT1RXMXc?oc=5", "source_name": "PR Newswire", "published_at": "2024-06-20T07:00:00+00:00", "published_display": "20 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ascentage Pharma signs R&D, commercialization deal worth up to $245M", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOR3JXeWFTSUxEaG9FdzdrSWJDRzdEMzRLMms5N3VnVEJGamthR3BqeTRLQW5wX214NnZDLS1lekxQY2k1Z1BmVVNYSGFaLWlZNWM1Rk0tNVU3dFhycEkzNDJRR3h0VmszRjhMcFh0eElCcXdrbkgzYzJOX1BYOVFXY1ZJS3pqX2w5aElaY3gtN0FSbVdBNEpwN3RoV1pnUUFoUlh4OA?oc=5", "source_name": "The Business Journals", "published_at": "2021-07-15T07:00:00+00:00", "published_display": "15 Jul 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 85, "total_relevant": 17, "sentiment_summary": {"positive": 1, "negative": 1, "neutral": 15, "score": 50, "total": 17, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 89, "events": [{"event": "general", "label": "Market update", "weight": 7.7, "count": 14}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 36.36, "latest_week": "2026-07-10", "one_week_move": -1.4, "four_week_move": 4.2, "twelve_week_move": -31.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.810673, "market_dynamics_buy_signal": false, "relative_strength": -31.949994, "fair_value_gap": -11.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 46.9697, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.4% over one week, +4.2% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "GlobeNewswire", "count": 2}, {"label": "The Business Journals", "count": 2}, {"label": "TipRanks", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "Market source", "count": 1}, {"label": "webull.com", "count": 1}, {"label": "citybiz", "count": 1}, {"label": "Stock Titan", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 17}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 14}, {"label": "Earnings", "count": 2}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "89/100 classification confidence."}, {"label": "Company focus", "value": "17", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.4% over one week, +4.2% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Ascentage Pharma Corrects AGM Date for Share Incentive Scheme Mandate"}], "updated_at": "2026-07-18T04:23:43.789528+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}